Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogens and atherosclerosis

L Nathan1, G Chaudhuri

  • 1Department of Obstetrics and Gynecology, University of California, Los Angeles, School of Medicine 90095-1740, USA.

Annual Review of Pharmacology and Toxicology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.

Oncogene·2017
Same author

Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.

Oncogene·2016
Same author

Oxidative stress specifically downregulates survivin to promote breast tumour formation.

British journal of cancer·2013
Same author

Reduced association of anti-apoptotic protein Mcl-1 with E3 ligase Mule increases the stability of Mcl-1 in breast cancer cells.

British journal of cancer·2011
Same author

Status of HFE mutation in thalassemia syndromes in north India.

Annals of hematology·2007
Same author

Bio-available Zn2+ in the growth medium as a cue for Leishmania to express its protective surface protease.

Annals of tropical medicine and parasitology·2007
Same journal

Navigating the Computational Landscape for Drug Repurposing.

Annual review of pharmacology and toxicology·2026
Same journal

Microplastics and Atherosclerosis: Mechanisms.

Annual review of pharmacology and toxicology·2026
Same journal

Treating Pregnant and Lactating Women: Insights from Clinical Pharmacology.

Annual review of pharmacology and toxicology·2026
Same journal

<i>Caenorhabditis elegans</i> as a Model System for Environmental Mitotoxicants.

Annual review of pharmacology and toxicology·2025
Same journal

Introduction to the Theme "New Approaches, Technology, and Techniques That Advance Pharmacology and Toxicology".

Annual review of pharmacology and toxicology·2025
Same journal

A Mechanistic Framework for Repurposing FDA-Approved Drugs to Combat Antimicrobial Resistance: The Case of <i>Staphylococcus aureus</i>.

Annual review of pharmacology and toxicology·2025
See all related articles

Estrogens protect women from heart disease by improving cholesterol levels and preventing artery hardening. They also have direct beneficial effects on blood vessels, reducing inflammation and improving blood flow.

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Vascular Biology

Background:

  • Estrogens are known to prevent heart disease in women.
  • Estrogens have demonstrated a capacity to slow atherogenesis in animal models.
  • Cardiovascular disease prevention by estrogens involves multiple steps in the atherogenic process.

Purpose of the Study:

  • To elucidate the multifaceted mechanisms by which estrogens exert cardioprotective effects.
  • To explore the impact of estrogens on lipoprotein metabolism and oxidative stress.
  • To investigate the direct vascular actions of estrogens on endothelial and smooth muscle cells.

Main Methods:

  • Analysis of estrogen's effects on lipoprotein profiles (HDL, LDL).
  • Evaluation of estrogen's role in preventing LDL oxidative modification.

Related Experiment Videos

  • Assessment of estrogen's influence on endothelial adhesion molecules and chemokine expression.
  • Examination of estrogen's impact on vascular reactivity and vasodilation.

    • Main Results:

    • Estrogens favorably alter lipoprotein profiles, increasing HDL and decreasing LDL.
    • Estrogens inhibit the oxidative modification of LDL, a key atherogenic event.
    • Estrogens reduce the expression of adhesion molecules and chemokines, mitigating monocyte recruitment.
    • Estrogens enhance vascular reactivity, promoting vasodilation and potentially preventing clinical cardiovascular events.

    Conclusions:

    • Estrogens offer protection against cardiovascular disease through diverse mechanisms.
    • Benefits include improved lipid profiles, reduced LDL oxidation, and anti-inflammatory vascular effects.
    • Estrogen's modulation of vascular reactivity contributes to its cardioprotective role.